| Composition | Rosuvastatin 20mg Aspirin 75mg |
|---|---|
| Dosage | CAPSULE |
| Packing Size | 10×10 |
| Packing | Strip |
ROZVIN AS 20/75 is a dual-action cardiovascular therapy combining Rosuvastatin 20 mg, a potent lipid-lowering statin, with Aspirin 75 mg, a low-dose antiplatelet agent. This combination is designed to effectively manage cholesterol levels while reducing the risk of blood clots, providing comprehensive cardiovascular protection in patients at high risk of heart attack, stroke, or atherosclerosis.
By addressing both dyslipidemia and platelet aggregation, ROZVIN AS 20/75 ensures enhanced heart protection in a single convenient tablet.
Each tablet contains:
Rosuvastatin 20 mg – HMG-CoA reductase inhibitor that lowers LDL cholesterol, total cholesterol, and triglycerides, while increasing HDL cholesterol.
Aspirin 75 mg – Antiplatelet agent that prevents platelet aggregation, reducing the risk of thrombotic cardiovascular events.
Tablet
Lipid-Lowering & Antiplatelet Therapy / Cardiovascular Protection
ROZVIN AS 20/75 Tablets are indicated for:
Patients with hypercholesterolemia or mixed dyslipidemia at high cardiovascular risk
Prevention of heart attack, stroke, or other thrombotic events
Secondary prevention in patients with previous myocardial infarction or coronary artery disease
Patients requiring intensive cholesterol management combined with antiplatelet therapy
Rosuvastatin inhibits the HMG-CoA reductase enzyme, reducing cholesterol synthesis in the liver and improving the lipid profile.
Aspirin irreversibly inhibits platelet aggregation, preventing thrombus formation and lowering the risk of cardiovascular events.
The combination addresses cholesterol management and blood clot prevention simultaneously, providing effective dual cardiovascular protection.
Recommended Dose: As prescribed by the physician, usually once daily
Route: Oral
Duration: Long-term therapy as advised by a healthcare provider
Note: Regular monitoring of lipid profile, liver function, and bleeding risk is recommended during therapy.
Reduces LDL cholesterol and triglycerides
Increases HDL cholesterol
Prevents platelet aggregation and thrombus formation
Reduces risk of heart attack, stroke, and atherosclerosis
Convenient once-daily tablet enhances patient compliance
ROZVIN AS 20/75 is generally well tolerated. Possible side effects include:
Mild gastrointestinal discomfort (nausea, abdominal pain)
Headache or dizziness
Muscle pain or weakness (rare, associated with statins)
Increased bleeding risk due to Aspirin
Patients should consult their physician if side effects persist or worsen.
Avoid in patients with active bleeding disorders or history of hemorrhagic stroke
Use with caution in liver or kidney impairment
Not recommended during pregnancy or lactation
Inform your doctor about other medications to prevent drug interactions
Regular monitoring of liver enzymes, lipid profile, and bleeding risk is advised
Store below 25°C, in a dry place away from sunlight. Keep out of reach of children.
Brand Name: ROZVIN AS 20/75
Composition: Rosuvastatin 20 mg + Aspirin 75 mg
Dosage Form: Tablet
Therapeutic Class: Lipid-Lowering & Antiplatelet / Cardiovascular Protection
Manufacturer: [Insert Company Name]
Packaging: [Example: 10×10 Tablets / Strip]
Combines high-potency cholesterol management with antiplatelet therapy in a single tablet
Provides dual cardiovascular protection for high-risk patients
Convenient once-daily dosing improves adherence
Manufactured under GMP-certified quality standards
ROZVIN AS 20/75 (Rosuvastatin 20 mg + Aspirin 75 mg Tablets) provides intensive dual cardiovascular protection by effectively lowering cholesterol and preventing platelet aggregation. This combination therapy reduces the risk of heart attack, stroke, and atherosclerosis, supporting long-term heart health and overall cardiovascular wellness.
